Innovent Biologics and Lilly expand collaboration agreement to commercialize BTK inhibitor, Jaypirca in Mainland China: San Francisco Tuesday, December 17, 2024, 11:00 Hrs [IST] I ...
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Crinecerfont is the first new treatment in 70 years for classic CAH and the only one that directly reduces excess ...
Affiliate content. Discover the 14 best colostrum supplements, offering exceptional options to support immunity, gut health, ...
The latest data from a new CDC report show a 700% plus increase in overdose deaths involving the fentanyl analog carfentanil ...
The Brighterside of News on MSN2d
New diabetes drug HPH-15 proves to be significantly better than existing wonder drugsDiabetes, a chronic condition impacting millions globally, often brings along complications like insulin resistance and fatty ...
Ajna BioSciences and British American Tobacco, yielded positive results from a phase-1 dose trial of AJA001, its cannabis-based drug candidate to treat symptoms of autism spectrum disorder ・Results ...
Recursion Pharmaceuticals is reshaping drug discovery with AI, strategic partnerships, and financial discipline for long-term investors. Explore more details here.
A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...
NewAmsterdam Pharma's obicetrapib demonstrates strong phase 3 results. Discover why NAMS stock could rise as further studies ...
If you're considering a reliable way to manage stress and anxiety, CBDistillery's 30mg Broad Spectrum CBD Anytime Gummies may ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigatio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback